Eli Lilly CEO on 1Q Results, Drug Pricing, Pharma Margins

The video discusses the company's revenue growth, highlighting the impact of new products and challenges like patent expirations. It addresses price pressures in the pharmaceutical market, focusing on strategies to expand access and manage pricing. The discussion also covers the company's commitment to achieving specific margin goals and investments in new products. Finally, it explores the political landscape's influence on healthcare policy, emphasizing the importance of innovation and access to healthcare.

What strategies is the company implementing to improve access to their medicines?

What is the company's goal for operating margins in the pharma business?